Published in J Anal Toxicol on October 08, 1983
The Washington Heights-Inwood Genetic Study of Essential Tremor: methodologic issues in essential-tremor research. Neuroepidemiology (1997) 2.96
Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology (2007) 2.41
Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology (2012) 2.26
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology (2006) 2.25
Accuracy of family history data on Parkinson's disease. Neurology (2003) 2.15
Reliability between two observers using a protocol for diagnosing essential tremor. Mov Disord (1998) 2.11
Hormones of the vertebrate host controlling ovarian regression and copulation of the rabbit flea. Nature (1966) 1.77
Diagnostic criteria for essential tremor: a population perspective. Arch Neurol (1998) 1.77
Next-generation and whole-genome sequencing in the diagnostic clinical microbiology laboratory. Eur J Clin Microbiol Infect Dis (2012) 1.73
Delayed-onset cerebellar syndrome. Arch Neurol (1996) 1.65
Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study. Neurology (2010) 1.57
Home oxygen for children with acute bronchiolitis. Arch Dis Child (2008) 1.55
Risk of tremor and impairment from tremor in relatives of patients with essential tremor: a community-based family study. Ann Neurol (2001) 1.55
Phenomenology and psychopathology related to psychogenic movement disorders. Adv Neurol (1995) 1.51
A teaching videotape for the assessment of essential tremor. Mov Disord (2001) 1.45
Large-image-format computed tomography imaging spectrometer for fluorescence microscopy. Opt Express (2001) 1.44
Does a screening questionnaire for essential tremor agree with the physician's examination? Neurology (1998) 1.43
Acute recovery from patterns in stroke patients: neuropsychological factors. Med J Aust (1980) 1.36
Idiopathic torsion dystonia linked to chromosome 8 in two Mennonite families. Ann Neurol (1997) 1.34
Clinical pharmacokinetics of high dose mebendazole in patients treated for cystic hydatid disease. Eur J Clin Pharmacol (1982) 1.27
Test-retest reliability of patient information on age of onset in essential tremor. Mov Disord (2000) 1.24
Adult onset tic disorders. J Neurol Neurosurg Psychiatry (2000) 1.21
Carcinogenicity, metabolism and Ki-ras proto-oncogene activation by 7,12-dimethylbenz[a]anthracene in rainbow trout embryos. Carcinogenesis (1993) 1.20
Clinical subtypes of essential tremor. Arch Neurol (2000) 1.19
Neuregulins increase alpha7 nicotinic acetylcholine receptors and enhance excitatory synaptic transmission in GABAergic interneurons of the hippocampus. J Neurosci (2001) 1.18
Differences in the prevalence of essential tremor among elderly African Americans, whites, and Hispanics in northern Manhattan, NY. Arch Neurol (1995) 1.17
The natural history of embouchure dystonia. Mov Disord (2001) 1.15
How normal is 'normal'? Mild tremor in a multiethnic cohort of normal subjects. Arch Neurol (1998) 1.15
Clinical characteristics of essential tremor: data from a community-based study. Mov Disord (1998) 1.13
Aromatic L-amino acid decarboxylase deficiency: clinical features, treatment, and prognosis. Neurology (2004) 1.10
Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD. Neurology (2003) 1.09
A comparison of different bedside tests for essential tremor. Mov Disord (1999) 1.09
Chronic fatigue syndrome, the immune system and viral infection. Brain Behav Immun (2011) 1.08
Is essential tremor symmetric? Observational data from a community-based study of essential tremor. Arch Neurol (1998) 1.03
Family history information on essential tremor: potential biases related to the source of the cases. Mov Disord (2001) 1.01
In vivo and in vitro metabolism of gomphoside, a cardiotonic steroid with doubly-linked sugar. J Steroid Biochem (1987) 0.98
Mild tremor in relatives of patients with essential tremor: what does this tell us about the penetrance of the disease? Arch Neurol (2001) 0.97
Plasma level of chlormethiazole and two metabolites after oral administration to young and aged human subjects. Eur J Clin Pharmacol (1977) 0.97
Does a pheromone-like factor from the nestling rabbit stimulate impregnation and maturation in the rabbit flea? Nature (1969) 0.96
Senile tremor. What is the prevalence and severity of tremor in older adults? Gerontology (2000) 0.95
Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology (1995) 0.94
Operative techniques and morbidity with subthalamic nucleus deep brain stimulation in 100 consecutive patients with advanced Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 0.93
Prevalence of asymptomatic tremor in relatives of patients with essential tremor. Arch Neurol (1997) 0.93
Incidence of drug and alcohol intake in road traffic accident victims. Med J Aust (1983) 0.93
Exclusion of the DYT1 locus in familial torticollis. Ann Neurol (1996) 0.93
4-Amino-3-(3'-methoxycarbonyl-2'-thioureido)benzophenone, a prodrug of mebendazole. Eur J Drug Metab Pharmacokinet (1984) 0.93
Intra- and interspecies variability of vertebrate high-pressure neurological syndrome. J Appl Physiol (1974) 0.92
Validity of family history data on essential tremor. Mov Disord (1999) 0.91
Structure-activity relationships of benzimidazole carbamates as inhibitors of mammalian tubulin, in vitro. Biochem Pharmacol (1985) 0.91
Engraftment of human hematopoietic precursor cells with secondary transfer potential in SCID-hu mice. Blood (1994) 0.90
Peritoneal coccidioidomycosis: case report and review. Clin Infect Dis (2000) 0.89
The effect of dose form on the bioavailability of mebendazole in man. Br J Clin Pharmacol (1985) 0.89
Parkinsonism, dystonia, and hemiatrophy. Mov Disord (2000) 0.89
Phenylalanine loading as a diagnostic test for DRD: interpreting the utility of the test. Mol Genet Metab (2004) 0.89
Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls. Clin Exp Immunol (2013) 0.88
Comparison of inhibition of polymerisation of mammalian tubulin and helminth ovicidal activity by benzimidazole carbamates. Vet Parasitol (1987) 0.88
The pharmacokinetics and bioavailability of a tracer dose of [3H]-mebendazole in man. Br J Clin Pharmacol (1985) 0.87
Thyrotoxic bone disease in women: a potentially reversible disorder. Ann Intern Med (1994) 0.87
Risperidone in Parkinson's disease. Lancet (1994) 0.85
The metabolism of butylated hydroxytoluene, (3,5-di-t-butyl-4-hydroxytoluene) in man. J Pharm Pharmacol (1970) 0.85
Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease. Neurology (1993) 0.85
Increased Rate of Sporadic and Recurrent Rare Genic Copy Number Variants in Parkinson's Disease Among Ashkenazi Jews. Mol Genet Genomic Med (2013) 0.84
Intrathecal baclofen in the treatment of dystonic storm. Mov Disord (1998) 0.84
A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease. Neurology (2001) 0.84
The disposition of biphenylacetic acid following topical application. Eur J Clin Pharmacol (1988) 0.84
Cutaneous electromyographic silent period findings in brachial dystonia. Neurology (1996) 0.84
Leaching of 2-(2-hydroxyethylmercapto) benzothiazole into contents of disposable syringes. J Pharm Sci (1981) 0.83
ET-1- and NO-mediated signal transduction pathway in human brain capillary endothelial cells. Am J Physiol Cell Physiol (2003) 0.83
Speech dysfluency exacerbated by levodopa in Parkinson's disease. Mov Disord (2001) 0.83
Simple enumerations of peripheral blood natural killer (CD56+ NK) cells, B cells and T cells have no predictive value in IVF treatment outcome. Hum Reprod (2005) 0.82
An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome. Hum Reprod (2004) 0.82
Cyst and host tissue concentrations of mebendazole in patients undergoing surgery for hydatid disease. Med J Aust (1983) 0.82
Survival of social relationships following head injury. Int Disabil Stud (1989) 0.82
Postoperative hypoxemia and its treatment with nasal oxygen: polarographic study. Surgery (1965) 0.82
Novel lignans from a Cinnamomum sp. from Bougainville. Tetrahedron Lett (1969) 0.81
Allozyme variation and genetic relationships among species in the Carex willdenowii complex (Cyperaceae). Am J Bot (1998) 0.81
Hemi-inattention and the recovery patterns of stroke patients. Int Rehabil Med (1985) 0.80
Post-traumatic shoulder 'dystonia': persistent abnormal postures of the shoulder after minor trauma. Neurology (1998) 0.80
Cardenolide connection between overwintering monarch butterflies from Mexico and their larval food plant,Asclepias syriaca. J Chem Ecol (1986) 0.80
The relation between depression and parkin genotype: the CORE-PD study. Parkinsonism Relat Disord (2011) 0.80
The pharmacokinetics and bioavailability of mebendazole in man: a pilot study using [3H]-mebendazole. Br J Clin Pharmacol (1982) 0.80
French horn embouchure dystonia. Mov Disord (1999) 0.79
Metabolism of etidocaine in man. Xenobiotica (1976) 0.79
Two high-performance liquid chromatographic determinations for mebendazole and its metabolites in human plasma using a rapid Sep Pak C18 extraction. J Chromatogr (1980) 0.79
Preliminary observations on the biliary elimination of mebendazole and its metabolites in patients with echinococcosis. Eur J Clin Pharmacol (1983) 0.79
Nuclear magnetic resonance studies of interactions between cetomacrogol and phenol. J Pharm Pharmacol (1971) 0.79
Focal task-specific dystonia induced by peripheral trauma. Mov Disord (2000) 0.78
Activity of benzimidazole carbamates against L1210 mouse leukaemia cells: correlation with in vitro tubulin polymerization assay. Biochem Pharmacol (1985) 0.78
Relationship of clinical efficacy to postmortem-determined anatomic subthalamic stimulation in Parkinson syndrome. Clin Neuropathol (2008) 0.77
Emotional disorder and its assessment within the severe head injured population. Psychol Med (1988) 0.77
Ethnic differences in essential tremor. Arch Neurol (2000) 0.77
Head injuries--what happens to survivors. Med J Aust (1976) 0.76
Chemoprevention of cancer: review of the literature. Oncol Nurs Forum (1997) 0.76
A geste antagoniste device to treat jaw-closing dystonia. Mov Disord (1999) 0.76
Evidence for familial aggregation of tremor in normal individuals. Neurology (2001) 0.76
The metabolic and pharmacokinetic disposition of mebendazole in the rat. Eur J Drug Metab Pharmacokinet (1984) 0.75
Intrathecal baclofen. Neurology (1994) 0.75
Social deprivation and the handicapped child. A preschool experiment in the A.C.T. Med J Aust (1973) 0.75
Who are the aged who are a problem in modern society? A survey of the dependent aged in the A.C.T. Med J Aust (1973) 0.75